Asymmetry Capital Management welcomes James Yin, PhD to team.
M2 EQUITYBITES-February 13, 2018-Asymmetry Capital Management welcomes James Yin, PhD to team
(C)2018 M2 COMMUNICATIONS http://www.m2.com
Asset management firm Asymmetry Capital Management LP reported on Monday the addition of James Yin, PhD to the Asymmetry Investment Team.
Based in the company's San Francisco headquarters, Dr Yin will work as an analyst covering global therapeutics.
The Asymmetry team has over 42-years combined healthcare and healthcare investing experience across market cycles and macro events.
Previously, Dr Yin has conducted research at the National Institutes of Health (NIH) and the University of Minnesota where he participated in breakthrough research to solve the atomic structure of the Rous Sarcoma Virus Intasome. This research was published in the Journal Nature in February 2016.
((Comments on this story may be sent to firstname.lastname@example.org))